These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34608677)

  • 41. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupus anticoagulant in patients with COVID-19.
    Tvito A; Ben-Chetrit E; Zimmerman FS; Asher E; Helviz Y
    Int J Lab Hematol; 2021 Feb; 43(1):e17-e18. PubMed ID: 32915472
    [No Abstract]   [Full Text] [Related]  

  • 45. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.
    García-Arias M; Pascual-Salcedo D; Ramiro S; Ueberschlag ME; Jermann TM; Cara C; Martín-Mola E; Balsa A
    Mol Diagn Ther; 2013 Feb; 17(1):49-56. PubMed ID: 23329363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 48. Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection.
    Lignier G; Camaré C; Jamme T; Combis MS; Tayac D; Maupas-Schwalm F
    Infect Dis Now; 2024 Mar; 54(2):104860. PubMed ID: 38309645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
    Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
    J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Renzulli P; Seibold F
    Inflamm Bowel Dis; 2009 Dec; 15(12):1851-8. PubMed ID: 19462421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
    Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
    Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
    Hammer HB; Ødegård S; Syversen SW; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2010 Jan; 69(1):150-4. PubMed ID: 19095696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
    Acar A; Guzel S; Sarifakioglu B; Guzel EC; Guzelant AY; Karadag C; Kiziler L
    Clin Rheumatol; 2016 Nov; 35(11):2685-2692. PubMed ID: 27094943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.
    Shi H; Zuo Y; Yalavarthi S; Gockman K; Zuo M; Madison JA; Blair CN; Woodard W; Lezak SP; Lugogo NL; Woods RJ; Lood C; Knight JS; Kanthi Y
    medRxiv; 2020 Jul; ():. PubMed ID: 32511540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating Calprotectin as a Biomarker of COVID-19 Severity.
    Mahler M; Meroni PL; Infantino M; Buhler KA; Fritzler MJ
    Expert Rev Clin Immunol; 2021 May; 17(5):431-443. PubMed ID: 33750254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of anticardiolipin, antiphosphatidylserine, anti-β2 glycoprotein I, and antiphosphatidylcholine autoantibodies with canine immune thrombocytopenia.
    Chen YC; Chi LM; Chow KC; Chiou SH; Fan YH; Ho SP; Hsu YC; Hwang YC; Wu MX; Lee WM; Lin SL; Tsang CL; Mao FC
    BMC Vet Res; 2016 Jun; 12(1):106. PubMed ID: 27297331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.